Welcome to LookChem.com Sign In|Join Free

CAS

  • or
AKOS B013937, with the molecular formula C15H17NO3, is a synthetic chemical compound that does not occur naturally. It is widely recognized for its high purity and stability, making it an essential building block in the pharmaceutical and research industries for the synthesis of a range of organic compounds.
Usage:
Used in Pharmaceutical Industry:
AKOS B013937 is used as a precursor in the production of pharmaceutical drugs for its ability to contribute to the development of new medications and enhance existing drug formulations.
Used in Research Industry:
AKOS B013937 is used as a reagent in organic synthesis for its role in facilitating various chemical reactions and experiments, thereby aiding in the advancement of scientific research and understanding of organic chemistry.

17431-97-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 17431-97-9 Structure
  • Basic information

    1. Product Name: AKOS B013937
    2. Synonyms: 2-Methyl-2-(4-nitrophenoxy)propanoic acid;2-methyl-2-(4-nitrophenoxy)propanoic acid(SALTDATA: FREE);Propanoic acid, 2-Methyl-2-(4-nitrophenoxy)-;CHEMBRDG-BB 3013937;ART-CHEM-BB B013937;AKOS B013937
    3. CAS NO:17431-97-9
    4. Molecular Formula: C10H11NO5
    5. Molecular Weight: 225.2
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 17431-97-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 394.3°Cat760mmHg
    3. Flash Point: 192.3°C
    4. Appearance: /
    5. Density: 1.328g/cm3
    6. Vapor Pressure: 6.34E-07mmHg at 25°C
    7. Refractive Index: 1.561
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: AKOS B013937(CAS DataBase Reference)
    11. NIST Chemistry Reference: AKOS B013937(17431-97-9)
    12. EPA Substance Registry System: AKOS B013937(17431-97-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 17431-97-9(Hazardous Substances Data)

17431-97-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17431-97-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,3 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 17431-97:
(7*1)+(6*7)+(5*4)+(4*3)+(3*1)+(2*9)+(1*7)=109
109 % 10 = 9
So 17431-97-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H11NO5/c1-10(2,9(12)13)16-8-5-3-7(4-6-8)11(14)15/h3-6H,1-2H3,(H,12,13)

17431-97-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methyl-2-(4-nitrophenoxy)propanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17431-97-9 SDS

17431-97-9Relevant articles and documents

Synthesis and preliminary antihyperlipidaemic activities evaluation of andrographolide derivatives

Wang, Bin,Tang, Chunlei,Han, Yaodan,Guo, Ruzhou,Qian, Hai,Huang, Wenlong

, p. 293 - 298 (2012)

Recent studies indicated that andrographolide was a potential antihyperlipidaemic therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their antihyperlipidaemic activities were evaluated in vivo. As compared with TG, TC, HDL-C and LDL-C concentrations, some of the derivatives exhibited better antihyperlipidaemic effects than positive control atromide. Therein, compound 6i, which was the most potent compound, could serve as a new lead for further development of antihyperlipidaemic agents.

Synthesis, In Vitro, In Vivo and In Silico Antidiabetic Bioassays of 4-Nitro(thio)phenoxyisobutyric Acids Acting as Unexpected PPARγ Modulators: An In Combo Study

Almanza-Pérez, Julio Cesar,Chávez-Silva, Fabiola,Colin-Lozano, Blanca,Estrada-Soto, Samuel,Hidalgo-Figueroa, Sergio,Navarrete-Vazquez, Gabriel,Torres-Gomez, Héctor

, (2022/01/24)

Four isobutyric acids (two nitro and two acetamido derivatives) were prepared in two steps and characterized using spectral analysis. The mRNA concentrations of PPARγ and GLUT-4 (two proteins documented as key diabetes targets) were increased by 3T3-L1 ad

ipso Nitration in p-halophenyl ethers

Clewley, Robin G.,Fischer, Alfred,Henderson, George N.

, p. 1472 - 1479 (2007/10/02)

Addition of nitronium ion ipso to halogen occurs on nitration of the p-haloanisoles in acetic anhydride at -60 deg C.In the cases of p-fluoro- and p-chloro-anisole, addition of the nitronium ion is reversible and only small amounts of ipso products are obtained.With p-bromoanisole nitrodebromination occurs.When p-halophenyl ethers containing a trapping substituent, e.g., 2-(4-chlorophenoxy)-2-methylpropanoic acid, are used as substrates, substantial amounts of the spiro diene with nitro ipso to halogen, e.g., 3,3-dimethyl-8-chloro-8-nitro-1,4-dioxaspirodeca-6,9-dien-2-one, can be isolated.The results demonstrate that extensive ipso attack at the halogen-substituted position is general in the nitration of p-halophenyl ethers.Key words: ipso nitration, ether, diene, p-haloanisole.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17431-97-9